G6PD and non-small cell lung carcinoma: Further investigations have unveiled metabolic disruptions within NSCLC tissues, with elevated expression levels of metabolic enzymes such as glucose-6-phosphate dehydrogenase (G6PD) and succinate dehydrogenase (SDH) compared to paracancerous tissues [47].